Do Queasy Side Effects Mean the End of Weight-loss Drug Stock Hype?
Least Shorted S&P 500 Stocks in August
J&J Leads H1 Healthcare Deals as Big Pharma Dealmaking Returns: Report
Merck Keytruda Cuts Mortality Risk in Gastric Cancer by 20%
GSK, ITeos Lung Cancer Therapy Outperforms Jemperli in Mid-stage Trial
Roche Group's Genentech Announces FDA Approves Ocrevus Zunovo As The First And Only Twice-A-Year 10-Minute Subcutaneous Injection For People With Relapsing And Progressive Multiple Sclerosis